WASHINGTON - November 2, 2016 - A substudy of the PARTNER I Trial and Continued Access Registry found that hemodynamic trends in patients who received transcatheter aortic valve replacement (TAVR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback